XRCC1 and urinary bladder carcinoma: After screening the titles and abstracts, 63 were excluded (40 did not examine XRCC1 R399Q, R194W and R280H Polymorphisms and bladder cancer risk, 23 were overlapped studies among the three databases) and only 39 full-text publications were preliminarily identified for further detailed evaluation (Figure 1).